Find Nonprofit and Small Business Grants

Advance Search

Only Available for Paid Subscribers
Clear Filters
Search Filters

The Role of Health Policy and Health Insurance in Improving Access to and Performance of Cancer Prevention, Early Detection, and Treatment Services

Grants to USA Nonprofits and Individuals for Research
on the Relationship between Cancer Care and Healthcare Policy

Agency Type:

Foundation / Corporation

Funding Source:

Add to My Calendar 

American Cancer Society (ASC)

Deadline Date:

10/15/18 5:00 PM EST - Electronic application deadline only; Paper application copy deadline is 04/03/18.

Description:

Request a Grant Writer

Grants to USA and territories nonprofit organizations and individual investigators for research on the correlation between healthcare policy issues and cancer prevention, control, and treatment. Funding is intended for innovative research projects that focus on the changes in national, state, and/or local policy and the response to these changes by healthcare systems, insurers, payers, communities, practices, and patients.

A clear understanding of these changes can help clinicians, health systems, public health and public policy professionals, patient and consumer advocates, and providers to identify and guide needed improvements in cancer prevention and control and health care and health more broadly. Findings from this research may also inform advocacy and policy development by the American Cancer Society Cancer Action Network (ASC CAN) in the context of meaningful health care reform by assessing outcomes related to the structure of the health system on availability, administrative simplicity, adequacy, and affordability of coverage, referred to as the 4 A’s, which make up the Society and ACS CAN’s framework for reform.

The Foundation is keenly interested in supporting rapid learning research to study the effects of health policy changes on patients, providers, and health systems. This includes but is not limited to:
- Facilitators and barriers to care;
- Unintended consequences;
- Differential experiences and outcomes of patients seeking or receiving care;
- Best practice models for quality care; and,
- Economic Impact

Specific examples of potential research areas that may be applicable include the following, organized by the 4 A’s of meaningful healthcare reform:

Availability:
- Investigate factors impacting equity in cancer prevention, diagnostic, treatment, and survivorship services across populations based on availability of health insurance coverage, type of coverage, affordability, and health care setting.
- Compare and contrast access and outcomes by state to provide new knowledge pertaining to how insurance coverage or lack of coverage (including lack of expanded Medicaid coverage) impacts cancer screening, diagnostic, treatment, or palliative care services.
- Evaluate the impact of expanding health insurance coverage for previously uninsured or underinsured persons.

Affordability:
- Compare and contrast variations in health insurance benefit packages (including services, Rx formularies, and cost-sharing) on health care costs and the resulting impact on cancer prevention, diagnosis, treatment, and palliative and support care services.
- Examine how tobacco rating is impacting the affordability of and access to insurance coverage.
- Compare and contrast changes in health risk pool distribution and their impact on health care costs, health insurance enrollment, and access pre- and post-implementation of the Affordable Care Act of 2010.
- Test methods to improve the efficiency of health insurance coverage and utilization.
- Compare and contrast models for improving high quality patient-centered care such as Patient Centered Medical Homes, Accountable Care Organizations, and patient and provider incentives to encourage guideline-concordant care.

Adequacy:
- Compare and contrast the implementation of health insurance marketplaces to assess their impact to access to needed services and choice of providers, and on the adoption and completion of cancer screening, diagnostic, treatment, and palliative and supportive care services.
- Compare and contrast the transparency of key information (e.g., network providers, formularies, etc.) and the extent to which this information is provided in a consumer-friendly manner.

Administrative simplicity:
- Assess the effectiveness of strategies to educate consumers about healthcare benefits and their impact on the adoption and completion of cancer screening, diagnostics and treatment services.
- Conduct dissemination and implementation research of evidence-based strategies supporting patients in overcoming administrative barriers related to health insurance to facilitate the adoption and completion of cancer screening, diagnostic, treatment or palliative and supportive care services.

Acceptable study designs: The Foundation encourages investigators to submit innovative proposals using an array of study designs which may include interventional or non-interventional research such as case control studies, cohort studies, clinical trials, comparative effectiveness research, dissemination and implementation research, cross-sectional studies, ecological, or mixed methods research. For example:
- Mixed-method studies utilizing secondary analysis and original data collection.
- Conduct primary data collection in the form of surveys, key informant interviews, focus groups or other methods to capture patient level experiences and their perceived solutions.
- Make creative use of primary and secondary data sources (such as CMS data) to capture both demographic and outcome data, establish robust data bases, and create registries or methods for data standardization across large data sources.

Priority Focus on Health Equity Research in the Cancer Control and Prevention Research Program is restricted to: research studies in psychosocial, behavioral, health policy, or health services, which address cancer health equity and disparities.

For Health Equity applications in Cancer Control and Prevention, reviewers will assess the potential impact of the proposed study, if the specific aims are accomplished, in advancing the field pertaining to an aspect of the cancer continuum and the target areas of focus aimed to contribute to achieving health equity.

GrantWatch ID#:

GrantWatch ID#: 179336

Estimated Size of Grant:

- For a grant period of under 4 years, up to $200,000 in direct costs per year may be awarded, with a maximum of 20% per year going to indirect costs.
- For a grant period of 4 years, up to $165,000 in direct costs per year may be awarded, with a maximum of 20% per year going to indirect costs.
- For a grant period of 5 years, up to $200,000 in direct costs per year may be awarded, with a maximum of 20% per year going to indirect costs.

Term of Contract:

Awards may not exceed a period of 4 years, with one exception. It is anticipated that some studies will require no more than two years to complete.

Health equity focused applications may propose a project period of up to 5 years if the study involves mixed methods utilizing both primary data and secondary collection to obtain qualitative and quantitative data.

Additional Eligibility Criteria:

Applications may be submitted by nonprofit institutions located within the United States, its territories, and the Commonwealth of Puerto Rico.

Independent investigators at all stages of their career are eligible to apply. The usual ACS restriction to investigators within the first six years of their initial independent research appointment for the Research Scholar grant applicants does not apply to this RFA.

The Society's research grants do not provide funds (direct budget) for such items as:
- Secretarial or administrative salaries
- Student tuition and student fees including graduate and undergraduate
- Foreign travel (special consideration given for attendance at scientific meetings held in Canada)
- Books and periodicals
- Membership dues
- Office and laboratory furniture
- Office equipment and supplies
- Rental of office or laboratory space
- Recruiting and relocation expenses
- Non-medical services to patients (travel to a clinical site or patient incentives are allowable expenses)
- Construction, renovation, or maintenance of buildings or laboratories

Pre-Application Information:

Electronic Application Deadline: April 2, 2018
Paper Application Copy Deadline: April 3, 2018

Timeline:
- Deadline: April 2
- Peer Review Meeting: June
- Preliminary Notification: August
- Council Meeting: September
- Grantee Notification: October
- Activation: January 1

- Deadline: October 15
- Peer Review Meeting: January
- Preliminary Notification: March
- Council Meeting: March
- Grantee Notification: April
- Activation: July 1

Applicants are strongly advised to verify their eligibility prior to preparing an application. Applications that do not comply with eligibility criteria will be administratively disapproved.

Applications for grants and awards must be submitted as paper and electronic copies via proposalCENTRAL. The electronic applications must be submitted at the proposalCENTRAL website by close of business (5:00 PM EST) on the specified deadline date. For the convenience of the applicant, a paper copy is due one day after submission of the electronic copy. If the deadline falls on a weekend or holiday, applications will be accepted the following business day.

Following review, preliminary information regarding the status of an application will be emailed along with instructions to download copies of the reviewers’ critiques. The notification will also indicate the likelihood of funding as described by one of the following phrases: experience suggests that (a) the applicant's application has been recommended for funding, (b) the Foundation cannot predict the likelihood of funding at this time or (c) the applicant's application is not likely to be funded. Please note that all final funding decisions are made by the Council for Extramural Grants which typically meets in March and September. Applicants may call the Extramural Grants Department at any time during the review cycle. The Program Director and Program Coordinator will shepherd the application through the entire process. Following receipt and careful consideration of the critiques, applicants are encouraged to contact their Program Director to discuss their review. For those applicants considering resubmission, it is strongly encouraged that they contact their Program Director well in advance of the next deadline.

Applicants proposing health equity research must upload a Cancer Control and Prevention Health Equity Statement (page 8.3). This statement should provide a brief summary outlining the targeted area(s) of health equity, study population and how the proposed research is anticipated to contribute to improving health equity relevant to cancer. Applicants must describe how the anticipated findings will advance the field beyond what is already known pertaining to an aspect of the cancer continuum and one or more of the social determinants of health (see Priority Area Focused on Health Equity description). Examples of research in this area include (but are not limited to) improvement in risk reduction behaviors, access to cancer prevention, early detection, diagnosis, and/or treatment services; reduction in cancer morbidity, mortality, symptom burden or costs, or improvements in quality of care or quality of life or health policy impact.

For questions about the Research Scholar Grant mechanism please contact Chanda Felton, Program Coordinator of the Cancer Control and Prevention Research program

Deadlines:
https://www.cancer.org/research/we-fund-cancer-research/apply-research-grant/grant-types/grant-application-deadlines.html

Key Cancer Provisions in the Affordable Care Act:
https://www.acscan.org/policy-resources/key-cancer-provisions-affordable-care-act

Contact Information:

Before starting your grant application, please review the funding source's website listed below for updates/changes/addendums/conferences/LOIs.

Online application:
http://proposalcentral.altum.com/

Chanda Felton, Program Coordinator of the Cancer Control and Prevention Research program
chanda.felton@cancer.org

The American Cancer Society, Inc.
National Home Office
Extramural Research Department
250 Williams Street NW, 6th Floor
Atlanta, GA 30303

Voice: (404) 329-7558
Fax: (404) 417-5974
Web site: http://www.cancer.org
Email: grants@cancer.org

The American Cancer Society
Extramural Research Department
250 Williams Street NW
Atlanta, GA 30303
404-329-7558

Additional information and help can be obtained through proposal CENTRAL customer support desk:

By phone: 1-800-875-2562 toll-free
By email: pcsupport@altum.com

URL for Full Text (RFP):

Geographic Focus:

USA: Alabama;   Alaska;   Arizona;   Arkansas;   California;   Colorado;   Connecticut;   Delaware;   Florida;   Georgia;   Hawaii;   Idaho;   Illinois;   Indiana;   Iowa;   Kansas;   Kentucky;   Louisiana;   Maine;   Maryland;   Massachusetts;   Michigan;   Minnesota;   Mississippi;   Missouri;   Montana;   Nebraska;   Nevada;   New Hampshire;   New Jersey;   New Mexico;   New York City;   New York;   North Carolina;   North Dakota;   Ohio;   Oklahoma;   Oregon;   Pennsylvania;   Rhode Island;   South Carolina;   South Dakota;   Tennessee;   Texas;   Utah;   Vermont;   Virginia;   Washington, DC;   Washington;   West Virginia;   Wisconsin;   Wyoming

USA Territories: American Samoa (USA)   Guam (USA)   Puerto Rico (USA)   Virgin Islands (USA)   Northern Mariana Islands (USA)